CN101559127A - 一种治疗ⅱ级化疗性静脉炎的中药膏剂及制备方法 - Google Patents
一种治疗ⅱ级化疗性静脉炎的中药膏剂及制备方法 Download PDFInfo
- Publication number
- CN101559127A CN101559127A CNA2009100157045A CN200910015704A CN101559127A CN 101559127 A CN101559127 A CN 101559127A CN A2009100157045 A CNA2009100157045 A CN A2009100157045A CN 200910015704 A CN200910015704 A CN 200910015704A CN 101559127 A CN101559127 A CN 101559127A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- grade
- treating
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 208000001297 phlebitis Diseases 0.000 title claims abstract description 20
- 230000000973 chemotherapeutic effect Effects 0.000 title claims abstract description 18
- 239000002674 ointment Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 229940099259 vaseline Drugs 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 241000245240 Lonicera Species 0.000 claims description 4
- 241000736199 Paeonia Species 0.000 claims description 4
- 241000581682 Sanguisorba Species 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 13
- 230000002757 inflammatory effect Effects 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000000843 powder Substances 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 206010020718 hyperplasia Diseases 0.000 abstract description 4
- 210000003462 vein Anatomy 0.000 abstract description 4
- 238000002512 chemotherapy Methods 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 241000894006 Bacteria Species 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- XYXONTIQGZKCNH-UYKXVWJOSA-N Lonicerin Natural products CO[C@@H]1O[C@@H](O)[C@H]([C@H]2C[C@H](O)[C@H](C)[C@@H]12)C(=O)OC XYXONTIQGZKCNH-UYKXVWJOSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 1
- SHPPXMGVUDNKLV-UHFFFAOYSA-N Veronicastroside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 SHPPXMGVUDNKLV-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- -1 inositol Saponin Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- SHPPXMGVUDNKLV-KMFFXDMSSA-N luteolin 7-O-neohesperidoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 SHPPXMGVUDNKLV-KMFFXDMSSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
一种治疗II级化疗性静脉炎的中药膏剂,其特征在于按照重量配比,原料包括以下组分:黄柏15~20份、丹参15~20份、桃仁15~20份、金银花15~20份、红花15~20份、芍药15~20份、地榆15~20份;所述一种治疗II级化疗性静脉炎的中药膏剂的制作方法,其特征在于包括以下步骤:按重量配比取各组分药研制成超细粉末混合均匀,按1∶4~5的比例将超细粉末加入已溶化的凡士林中搅拌制成。本发明一种治疗II级化疗性静脉炎的中药膏剂,应用方便,价格低廉,无毒副作用,具有清热解毒、消肿止痛、活血散瘀、抗菌消炎、敛湿抑菌、抑制炎性渗出及炎性增生的作用,针对性强,效果好,治愈率高,不仅减轻病人的痛苦,还提高了病人静脉的利用率,保障化疗的顺利进行。
Description
技术领域
本发明属于中药学技术领域,具体涉及一种治疗II级化疗性静脉炎的中药膏剂及制备方法。
背景技术
恶性肿瘤发病率呈逐年上升趋势,严重威胁着人们的健康,而静脉输注化疗药物是治疗恶性肿瘤的重要手段之一,由于化疗药物的细胞毒性作用明显,发泡性能强,药物对血管刺激性大,导致化疗性静脉炎发生率高达57.6%~87%。这不仅增加了患者的痛苦,同时也影响进一步的治疗甚至被迫终止治疗,因此保护血管是化疗顺利进行的关键。目前报道中药防治静脉炎的方法虽有很多,但其共同特点是,在静脉炎的整个演变过程中,只用单一方剂治疗,没有针对各期病理特点、临床表现,采取相应有效的方法,其疗效不佳。
发明内容
本发明的目的在于提供一种能够克服已有技术存在的缺陷,且有效率高达94%、治愈率达76.5%,选材容易、制备方便、费用低廉,无毒副作用的一种治疗II级化疗性静脉炎的中药膏剂及制备方法。
本发明中药以清热解毒、消肿止痛、活血散瘀、抗菌消炎、敛湿抑菌、抑制炎性渗出及炎性增生为治疗原则,达到有效治疗II级化疗性静脉炎的目的,防静脉壁继续受损害,制止静脉炎的病理进展。
本发明的技术方案是:一种治疗II级化疗性静脉炎的中药膏剂及制备方法,其特征在于按照重量配比,原料包括以下组分:黄柏15~20份、金银花15~20份、红花15~20份、芍药15~20份、地榆15~20份、丹参15~20份、桃仁15~20份;所述一种治疗II级化疗性静脉炎的中药膏剂的制作方法,其特征在于包括以下步骤:按重量配比取各组分药研制成超细粉末混合均匀,按1∶4~5的比例将超细粉末加入已溶化的凡士林中搅拌制成。
使用方法:用无菌棉签均匀涂抹一层中药膏剂,范围从穿刺静脉两侧3~4cm,沿静脉走向长8~10cm,每天3次,连续5天。
本发明一种治疗II级化疗性静脉炎的中药膏剂,所述黄柏:系清热燥湿药,有清热解毒燥湿的作用;所含的黄柏碱、黄柏酮等多种成分,有松弛肌肉和抗菌作用。金银花:为清热解毒药,有清热解毒、透散表邪、功善化毒作用;所含的绿原酸、异绿原酸、黄酮类、忍冬甙、肌醇皂甙有广谱抗菌作用,并能抑制炎性渗出及抑制炎性增生,有防血管硬索发生之效。红花、丹参:均为活血化瘀药,其活血、行血、通脉、止痛效果好,有改善外周血循环、抗凝、促纤溶作用。地榆:具有泻火解毒、凉血泄热、收敛止血、抗炎消肿作用。桃仁:为活血化瘀药,活血祛瘀力较强,具抗炎性渗出,促进炎性渗出液吸收的作用。
本发明的有益效果是:应用方便,价格低廉,无毒副作用,具有清热解毒、消肿止痛、活血散瘀、抗菌消炎、敛湿抑菌、抑制炎性渗出及炎性增生的作用,针对性强,效果好,治愈率高,不仅减轻病人的痛苦,还提高了病人静脉的利用率,保障化疗的顺利进行。
具体实施方式
实施例1:一种治疗II级化疗性静脉炎的中药膏剂,按照重量配比,原料包括以下组分:黄柏15份、金银花15份、红花15份、芍药15份、地榆15份、丹参15份、桃仁15份。所述中药膏剂的制作方法为:按重量配比取各组分药洗净焙干,研成颗粒大小为50微米粉末,按1∶4的比例将超细药粉加入已溶化的凡士林中调匀即成。
实施例2:一种治疗II级化疗性静脉炎的中药膏剂,按照重量配比,原料包括以下组分:黄柏20份、金银花20份、红花20份、芍药20份、地榆20份、丹参20份、桃仁20份。所述中药膏剂的制作方法为:按重量配比取各组分药洗净焙干,研成颗粒大小为50微米粉末,按1∶5的比例将超细药粉加入已溶化的凡士林中调匀即成。
治疗效果:
静脉炎疗效判定:一种治疗II级化疗性静脉炎的中药膏剂之疗效判定,主要依据血管弹性及疼痛缓解情况。用药5天为一个疗程。具体疗效分以下三级:治愈:1个疗程内红肿消退,血管弹性恢复,完全无疼痛或疼痛明显减轻;有效:1个疗程内红肿范围明显缩小,血管弹性有所恢复,疼痛减轻;无效:1个疗程后局部静脉炎表现无明显好转,疼痛无变化。
效果:应用该药方治疗34例II级化疗性静脉炎患者,其中治愈26例,显效6例,治愈率76.5%,有效率94%。
Claims (1)
1、一种治疗II级化疗性静脉炎的中药膏剂及制备方法,其特征在于按照重量配比,原料包括以下组分:黄柏15~20份、丹参15~20份、桃仁15~20份、金银花15~20份、红花15~20份、芍药15~20份、地榆15~20份;所述一种治疗II级化疗性静脉炎的中药膏剂的制作方法,其特征在于包括以下步骤:按重量配比取各组分药研制成超细粉末混合均匀,按1∶4~5的比例将超细粉末加入已溶化的凡士林中搅拌制成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100157045A CN101559127B (zh) | 2009-05-25 | 2009-05-25 | 一种治疗ⅱ级化疗性静脉炎的中药膏剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100157045A CN101559127B (zh) | 2009-05-25 | 2009-05-25 | 一种治疗ⅱ级化疗性静脉炎的中药膏剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101559127A true CN101559127A (zh) | 2009-10-21 |
CN101559127B CN101559127B (zh) | 2011-04-06 |
Family
ID=41218218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100157045A Expired - Fee Related CN101559127B (zh) | 2009-05-25 | 2009-05-25 | 一种治疗ⅱ级化疗性静脉炎的中药膏剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101559127B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008684A (zh) * | 2010-11-14 | 2011-04-13 | 贾荣娟 | 一种治疗ⅳ级化疗性静脉炎的中药组合物 |
CN104873612A (zh) * | 2015-06-06 | 2015-09-02 | 青岛辰达生物科技有限公司 | 一种预防化疗性静脉炎的中药组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1814099A (zh) * | 2005-11-18 | 2006-08-09 | 中山大学肿瘤防治中心 | 用于治疗与预防化学药物所致静脉损伤药物的用途 |
-
2009
- 2009-05-25 CN CN2009100157045A patent/CN101559127B/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008684A (zh) * | 2010-11-14 | 2011-04-13 | 贾荣娟 | 一种治疗ⅳ级化疗性静脉炎的中药组合物 |
CN104873612A (zh) * | 2015-06-06 | 2015-09-02 | 青岛辰达生物科技有限公司 | 一种预防化疗性静脉炎的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN101559127B (zh) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101167847B (zh) | 一种有效治疗皮肤病的中药白酒制剂 | |
CN101502580B (zh) | 一种治疗手足癣的外用药剂 | |
CN103479883B (zh) | 一种用于治疗糖尿病足溃疡的生肌愈疡油 | |
CN102641375A (zh) | 一种治疗头癣脚癣手癣甲癣体癣股癣的药物及其制备方法 | |
CN102552501B (zh) | 一种治疗外阴白斑的外用中药组合物 | |
CN103599181A (zh) | 一种治疗痤疮的药物 | |
CN101401860A (zh) | 一种治疗皮肤病的外用药物组合物 | |
CN101698017A (zh) | 一种消炎杀菌的软膏 | |
CN104013878A (zh) | 一种快速治疗脚气的足浴药醋及其制备方法 | |
CN101559127B (zh) | 一种治疗ⅱ级化疗性静脉炎的中药膏剂及制备方法 | |
CN103599492B (zh) | 一种治疗痤疮的药物 | |
CN102327586A (zh) | 一种治疗冻疮的药物及其制备方法 | |
CN103655873B (zh) | 一种治疗甲癣的外用药膏 | |
CN102772626B (zh) | 一种消炎解毒灭菌的药物组合物 | |
CN102058692B (zh) | 一种治疗ⅱ~ⅲ度放射性皮炎的外用中药组合物 | |
CN100531781C (zh) | 一种祛除疣痣的中药组合物 | |
CN102008684B (zh) | 一种治疗ⅳ级化疗性静脉炎的中药组合物 | |
CN104983978A (zh) | 治疗烧伤的外用药物组合物、治疗烧伤的外用药膏及其制作方法 | |
CN102078564B (zh) | 一种治疗ⅲ级化疗性静脉炎的外用中药组合物 | |
CN101618184B (zh) | 一种治疗2级、3级化疗性静脉炎的中药膏剂及制备 | |
CN101002821B (zh) | 疱疹软膏 | |
CN104398796A (zh) | 一种渗出性皮肤病用湿敷剂及其制备方法 | |
CN103120768A (zh) | 一种治疗病毒性心肌炎和心肌病的药物 | |
CN104173877A (zh) | 伤口快速愈合中药制剂及其制备方法 | |
CN105561077A (zh) | 一种治疗皮炎、湿疹的产品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110406 Termination date: 20120525 |